目的:探讨针刺治疗急性痛证的临床疗效,为临床镇痛提供新的思路和依据。方法:将符合诊断标准的急性肾绞痛患者54例,随机均分为针刺肾经与膀胱经相对穴组和肌注强痛定组,观察两组的总体临床疗效、不同时相点的疼痛程度(VAS,视觉模拟评分...目的:探讨针刺治疗急性痛证的临床疗效,为临床镇痛提供新的思路和依据。方法:将符合诊断标准的急性肾绞痛患者54例,随机均分为针刺肾经与膀胱经相对穴组和肌注强痛定组,观察两组的总体临床疗效、不同时相点的疼痛程度(VAS,视觉模拟评分)、疼痛开始缓解所需时间及不良反应发生情况。结果:两组总有效率比较无显著性差异(P>0.05)。组内比较除治疗后60 min和120 min外,余时相点VAS比较均有显著性差异(P<0.01)。组间比较治疗后10 min VAS、疼痛开始缓解所需时间及不良反应发生率分别比较,差异均有显著性意义(P<0.01、P<0.05)。结论:两者均能有效缓解肾绞痛症状,但相对穴对刺起效较快,具有较强的即刻止痛效果,且不良反应少。展开更多
Objective To compare the effects of pressing moxibustion at Baihui(GV 20)and Guanyuan(CV 4)combined with donepezil hydrochloride tablets and donepezil hydrochloride tablets alone on cognitive impairment in patients wi...Objective To compare the effects of pressing moxibustion at Baihui(GV 20)and Guanyuan(CV 4)combined with donepezil hydrochloride tablets and donepezil hydrochloride tablets alone on cognitive impairment in patients with mild to moderate Alzheimer's disease(AD),and to explore the mechanism of pressing moxibustion in the treatment of mild to moderate AD from the serum levels ofβ-amyloid 1-42(Aβ1-42),microtubule-associated protein tau and phosphorylated tau(P-tau).Methods A total of 76 patients with mild to moderate AD were randomly divided into an observation group(38 cases,4 cases dropped out)and a control group(38 cases,2 cases dropped out).Patients in the control group were given oral donepezil hydrochloride tablets(5 mg each time,once a day).On the basis of the control group,patients in the observation group were treated with pressing moxibustion at Baihui(GV 20)and Guanyuan(CV 4),5 cones per acupoint,once every other day,three times a week.Both groups were treated for 8 weeks.展开更多
文摘目的:探讨针刺治疗急性痛证的临床疗效,为临床镇痛提供新的思路和依据。方法:将符合诊断标准的急性肾绞痛患者54例,随机均分为针刺肾经与膀胱经相对穴组和肌注强痛定组,观察两组的总体临床疗效、不同时相点的疼痛程度(VAS,视觉模拟评分)、疼痛开始缓解所需时间及不良反应发生情况。结果:两组总有效率比较无显著性差异(P>0.05)。组内比较除治疗后60 min和120 min外,余时相点VAS比较均有显著性差异(P<0.01)。组间比较治疗后10 min VAS、疼痛开始缓解所需时间及不良反应发生率分别比较,差异均有显著性意义(P<0.01、P<0.05)。结论:两者均能有效缓解肾绞痛症状,但相对穴对刺起效较快,具有较强的即刻止痛效果,且不良反应少。
文摘Objective To compare the effects of pressing moxibustion at Baihui(GV 20)and Guanyuan(CV 4)combined with donepezil hydrochloride tablets and donepezil hydrochloride tablets alone on cognitive impairment in patients with mild to moderate Alzheimer's disease(AD),and to explore the mechanism of pressing moxibustion in the treatment of mild to moderate AD from the serum levels ofβ-amyloid 1-42(Aβ1-42),microtubule-associated protein tau and phosphorylated tau(P-tau).Methods A total of 76 patients with mild to moderate AD were randomly divided into an observation group(38 cases,4 cases dropped out)and a control group(38 cases,2 cases dropped out).Patients in the control group were given oral donepezil hydrochloride tablets(5 mg each time,once a day).On the basis of the control group,patients in the observation group were treated with pressing moxibustion at Baihui(GV 20)and Guanyuan(CV 4),5 cones per acupoint,once every other day,three times a week.Both groups were treated for 8 weeks.
